![Christopher Hart](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Postes actifs de Christopher Hart
Sociétés | Poste | Début | Fin |
---|---|---|---|
Creyon Bio, Inc.
![]() Creyon Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Creyon Bio, Inc. is a pre-clinical stage drug development company based in San Diego, CA. The company is focused on developing precision oligonucleotide-based medicines (OBMs) such as ASOs, siRNAs, guide RNAs, RNA editing guides, mRNAs, and aptamers. Creyon Bio uses a data-first approach to generate powerful datasets and develop machine learning models to uncover the engineering principles that make precision OBMs possible for patient populations of all sizes. The CEO of the company is Christopher E Hart. | Directeur/Membre du Conseil | - | - |
Directeur Général | - | - | |
President | - | - | |
Directeur Financier/CFO | - | 20/07/2023 |
Historique de carrière de Christopher Hart
Statistiques
Internationale
Etats-Unis | 2 |
Opérationnelle
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Director of Finance/CFO | 1 |
Sectorielle
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
Creyon Bio, Inc.
![]() Creyon Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Creyon Bio, Inc. is a pre-clinical stage drug development company based in San Diego, CA. The company is focused on developing precision oligonucleotide-based medicines (OBMs) such as ASOs, siRNAs, guide RNAs, RNA editing guides, mRNAs, and aptamers. Creyon Bio uses a data-first approach to generate powerful datasets and develop machine learning models to uncover the engineering principles that make precision OBMs possible for patient populations of all sizes. The CEO of the company is Christopher E Hart. | Commercial Services |
- Bourse
- Insiders
- Christopher Hart
- Expérience